Stephen Cornelissen/LinkedIn
Feb 4, 2026, 08:05
Stephen Cornelissen Honors the Life-Saving Impact of Blood Donation on World Cancer Day
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”On World Cancer Day, I’m reminded that behind every diagnosis is a person and a story shaped by resilience, fear, hope, and the people who stand beside them.
Blood cancer patients are the largest users of donated blood in Australia.
More than a third of all whole blood donations support cancer treatment, helping patients stay strong enough to undergo chemotherapy and other intensive therapies.
These donations don’t treat the cancer itself, but they make treatment possible.
It highlights the vital role Australian Red Cross Lifeblood donors play in supporting patients through treatment.”

Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:05Rounak Dubey: Reimagining Decision Support – ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: Don’t Let EDTA Fool You – When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 19:20Simos Kokkovos: 1st Ever Mobile Stroke Unit in Greece is on its way to Metropolitan Hospital
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia